Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
InhaleRx Limited (AU:IRX)
ASX:IRX
Holding AU:IRX?
Track your performance easily
IRX Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week RangeAU$0.01 - AU$0.06
Previous CloseAU$0.03
Volume0.00
Average Volume (3M)46.43K
Market Cap
AU$6.07M
Enterprise ValueAU$3.94M
Total Cash (Recent Filing)AU$2.13M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)―
Beta-0.81
Next Earnings
Feb 24, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares OutstandingN/A
10 Day Avg. Volume0
30 Day Avg. Volume46,426
Standard Deviation0.25
R-Squared0.05
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)314.00
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
InhaleRx Limited News
PremiumCompany Announcements
InhaleRx Ltd Hosts Investor Webinar on Future Strategies
PremiumCompany Announcements
InhaleRx Faces FDA Hold on New Drug Trial
PremiumCompany Announcements
InhaleRx’s IRX-211 Shows Promise in Phase 1 Trials
PremiumCompany Announcements
InhaleRx Director’s Stake Increases with New Options
PremiumCompany Announcements
InhaleRx Issues New Employee Incentive OptionsPremiumCompany Announcements
InhaleRx Limited AGM Shows Strong Shareholder BackingPremiumCompany Announcements
InhaleRx Limited Briefs on Annual General Meeting
PremiumCompany Announcements
InhaleRx Submits New Drug Application to FDAOptions Prices
Currently, No data available
---
Ownership Overview
22.89%
Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
77.11% Public Companies and
Individual Investors
IRX FAQ
What was InhaleRx Limited’s price range in the past 12 months?
InhaleRx Limited lowest share price was AU$0.01 and its highest was AU$0.06 in the past 12 months.
What is InhaleRx Limited’s market cap?
Currently, no data Available
When is InhaleRx Limited’s upcoming earnings report date?
InhaleRx Limited’s upcoming earnings report date is Feb 24, 2025 which is in 157 days.
How were InhaleRx Limited’s earnings last quarter?
InhaleRx Limited released its earnings results on Aug 30, 2024. The company reported -AU$0.004 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.004.
Is InhaleRx Limited overvalued?
According to Wall Street analysts InhaleRx Limited’s price is currently Overvalued.
Does InhaleRx Limited pay dividends?
InhaleRx Limited does not currently pay dividends.
What is InhaleRx Limited’s EPS estimate?
InhaleRx Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does InhaleRx Limited have?
InhaleRx Limited has 189,766,950 shares outstanding.
What happened to InhaleRx Limited’s price movement after its last earnings report?
InhaleRx Limited reported an EPS of -AU$0.004 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of InhaleRx Limited?
Currently, no hedge funds are holding shares in AU:IRX
---
InhaleRx Limited Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-34.69%
12-Months-Change
Fundamentals
Return on Equity
-252.23%
Trailing 12-Months
Asset Growth
-48.07%
Trailing 12-Months
Company Description
InhaleRx Limited
InhaleRx Ltd focuses on medical inhalation devices for the delivery of prescribed medicines. The Medihale Inhaler utilizes heat (not burn) technology, avoiding the production of pyrolytic toxins and carcinogenics often created when combusting plant material such as tobacco or cannabis leafs of flowers. The sealed tamper proof Medihale Pods provide patients with the additional security that the Medical Cannabis c-liquid is of good quality.
---
Technical Analysis
Althea Group Holdings Ltd.
―
Race Oncology Ltd.
―
Alcidion Group Limited
―
dorsaVi Limited
―
---